179 related articles for article (PubMed ID: 9564665)
1. Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy.
Heinrichs WL; Henzl MR
J Reprod Med; 1998 Mar; 43(3 Suppl):299-308. PubMed ID: 9564665
[TBL] [Abstract][Full Text] [Related]
2. Add-back therapy in the treatment of endometriosis-associated pain.
Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
4. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
5. An economically rational method of managing early-stage endometriosis.
Surrey E
Med Interface; 1997 Mar; 10(3):119-24. PubMed ID: 10172946
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
7. Current approaches to optimizing the treatment of endometriosis in adolescents.
Laufer MR
Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications.
Agarwal SK
J Reprod Med; 1998 Mar; 43(3 Suppl):293-8. PubMed ID: 9564664
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
[TBL] [Abstract][Full Text] [Related]
10. Primary gonadotropin-releasing hormone agonist therapy for suspected endometriosis: a nonsurgical approach to the diagnosis and treatment of chronic pelvic pain.
Barbieri RL
Am J Manag Care; 1997 Feb; 3(2):285-90. PubMed ID: 10169263
[TBL] [Abstract][Full Text] [Related]
11. Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain.
Al-Azemi M; Jones G; Sirkeci F; Walters S; Houdmont M; Ledger W
BJOG; 2009 Nov; 116(12):1646-56. PubMed ID: 19735378
[TBL] [Abstract][Full Text] [Related]
12. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
[TBL] [Abstract][Full Text] [Related]
13. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment.
Szendei G; Hernádi Z; Dévényi N; Csapó Z
Gynecol Endocrinol; 2005 Aug; 21(2):93-100. PubMed ID: 16109595
[TBL] [Abstract][Full Text] [Related]
14. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery.
Hemmings R
J Reprod Med; 1998 Mar; 43(3 Suppl):316-20. PubMed ID: 9564667
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Ishihara H; Kiyomizu M; Honjo H
Fertil Steril; 2008 Jun; 89(6):1831-5. PubMed ID: 17761178
[TBL] [Abstract][Full Text] [Related]
17. The clinical and economic benefits of GnRH agonist in treating endometriosis.
Glasser M
Am J Manag Care; 1999 May; 5(5 Suppl):S316-26. PubMed ID: 10537664
[No Abstract] [Full Text] [Related]
18. Does response to hormonal therapy predict presence or absence of endometriosis?
Jenkins TR; Liu CY; White J
J Minim Invasive Gynecol; 2008; 15(1):82-6. PubMed ID: 18262150
[TBL] [Abstract][Full Text] [Related]
19. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Lovelace Health Systems chronic pelvic pain protocol.
Kephart W
Am J Manag Care; 1999 May; 5(5 Suppl):S309-15. PubMed ID: 10537663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
